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Abstract. Commercial pure titanium is a recognized and accepted material for cortical bone tissue 
substitution. However, stress-shielding phenomena and lack of osseointegration result in significant 
limitations. This work is focused on the achievement of an effective solution for both problems via 
fabrication of porous titanium substrates coated with bioactive glass. Substrates were obtained 
through the space holder technique giving values of stiffness and yield strength compatible with 
cortical bone tissue to reduce the stress-shielding phenomenon. Titanium substrates were coated 
with different number of layers of bioactive glass 45S5 by dripping sedimentation. The substrates 
porosity was characterized by different techniques. Ultrasound, compression and micro-mechanical 
testing were used for mechanical properties evaluation. After substrates coating, the infiltration 
ability, coating homogeneity and structural integrity (chipping and cracking) were evaluated for 
each coating layer. The chemical composition of coating and phases were studied before and after in 
vitro tests in Simulated Body Fluid. The results showed more homogenous coating, adherence and 
greater hydroxyapatite growth for the tri-layer system in both dense and porous samples. Besides, 
the relation of Ca/P was closed to that of stoichiometric hydroxyapatite in the human body. The 
coated porous titanium could be potentially used in load bearing partial implants with improved 
osseointegration. 
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1. Introduction 
Diseases and aging influence the bone tissue quality, making a total or partial bone replacement 
by implants or prosthesis necessary. The implant functionality is affected by several factors: 
intrinsic properties of materials and components (shape and geometry features); host bone tissue 
(quality and quantity); and topography, biochemistry and surface energy of the biointerface between 
the bone and the implant [1]. Additionally, other factors related to the environmental stimulation 
also affect prostheses behavior, e.g mechanical stimulation (local and remote), the systemic 
immunological response (natural and modulated), and / or some medicine, drugs and systemic 
effects [1]. The biointerfacial properties are the main elements for the correct performance of the 
system. The goal of implant design is to reach a biofunctional (bone in-growth and osseointegration) 
and biomechanical (stiffness and yield strength) equilibrium [2]. Although commercial pure 
titanium (c.p. Ti) and its alloys are commonly used as bone implants [3], they exhibit some 
unsolved issues: stress shielding phenomenon and lack of osseointegration [2,4]. The reduction of 
the implant Young's modulus can be addressed by fabricating porous materials [5-9]. Regarding the 
improvement of osseointegration, implant surface modifications have been widely performed [2], 
[4-8] by implementing a variety of techniques that involve physical and chemical changes, e.g. 
controlling the surface roughness or obtaining bioactive surfaces [10]. 
The success of implants depends on material properties including mechanical behavior, 
microstructure and surface characteristics [11]. The surface plays an important role in the response 
of artificial devices in a biological environment making surface modification one of the most 
common approaches to improve the biocompatibility. Among bioceramics, hydroxyapatite 
[Ca10(PO4)6(OH)2] (HA) is known for its biocompatibility because of its similar chemical 
crystallographic structure to the mineral phase of living bone [12]. Hydroxyapatite is an 
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osteoinductive, nontoxic, non-immunogenic agent and has the ability to form strong chemical bonds 
with natural bone [13,14]. According to its chemical formula, HA has a Ca/P molar ratio of 1.67 
(5:3) which is close to the Ca/P ratio in bone minerals (between 1.37 and 1.87). [15] 
 
Bioactive glasses (BGs) are being increasingly investigated as promising scaffold materials for 
bone regeneration since the discovery of 45S5 BG by Larry Hench in 1969 [13]. BGs have a well-
recognized superior osteoconductivity, controlled biodegradability, the capability of activating 
osteogenic gene expression, angiogenic potential 0 [16], they promote the formation of bone 
mineral-like phases (including HA) and have drug delivery abilities [14,17]. Bioactive glasses 
exhibit high bioactivity through the release of dissolution ions such as Ca, P and Si, which may also 
affect gene expression in osteogenic cells and bone vascularisation, and could lead to the subsequent 
promotion of a high rate of bone formation [16]. A. Scislowska-Czarnecka et al. [18] tested the 
effect on macrophage activation after coating porous titanium substrates with BG by sol-gel 
technique, and compared it to different ceramic coatings. It was found that more cells were adhered 
to BG-Ti system than to other combinations, as well as to Ti substrate with no covering. The BG 
coating on porous titanium showed also good biocompatibility, not stimulating macrophages to an 
inflammatory response. 
 
The use of bioactive glasses is limited for load-bearing applications due to their brittleness. There 
are two processing methods to fabricate a glass: traditional melt-quenching (commercial bioactive 
glasses) and the sol-gel route (assembled nanoparticles – intrinsic nanoporosity). The 
implementation of most of the techniques for glass fabrication requires the control of a high number 
of parameters and a high cost. In terms of types, the main glasses are conventional silicate (similar 
to Bioglass® 45S5), phosphate-based and borate-based glasses. The interest of borate-based and 
phosphate-based glasses in soft tissue response is related to their fast dissolution compared to 
silicate-based glasses [19]. Nevertheless, BonAlive® (S53P4) has been highlighted in many clinical 
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trials. In this context, although there are more available data for S53P4 than for 45S5, the 
degradation rate of S53P4 in the human body is lower [19]. In addition, 45S5 and S53P4 cannot be 
produced as amorphous bioactive glass scaffolds due to their crystallization during the sintering. For 
this reason, they are mostly employed as bioactive coatings on inert metallic substrates. In terms of 
fabrication, the temperatures should be chosen carefully in order to avoid glass crystallization and 
substrate degradation [20]. 
Fully dense commercial pure Ti substrates coated with BG (bioactive glass 45S5) have been 
widely investigated [21]. However there has been only limited work focusing on BG coatings onto 
porous titanium substrates [22].The aim of this work is the fabrication of porous titanium substrates 
coated with BG by implementing a simple, repetitive and economical deposition technique, 
consisting on sedimentation by dripping. The materials combination offers a potential 
biomechanical (stiffness and yield strength) and biofunctional (ingrowth and osseointegration) 
equilibrium, recommended for partial cortical bone tissue substitution. 
2. Conclusions 
The study of the porous titanium substrates coated with 45S5 bioactive glass allows to conclude the 
following: 
 
1- A novel sedimentation technique was introduced to coat Ti substrates with 45S5 BG powder.  
The parameters to control are BG particle size, concentration, number of coating layers and 
thermal treatment. Using porous titanium substrates, combined with dripping sedimentation, 
involves the possibility of an economically and commercially viable alternative to obtain BG 
coatings for implants and scaffolds.  
2- The coated porous substrate has a better adherence than that of full dense titanium. This can be 
attributed to the roughness of the pore walls and the anchoring associated with the infiltration of 
BG particles into the pores. The size and content of the pores of the titanium substrates studied in 
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this work as well as the mechanical properties (E and yield strength) meet the requirements of the 
cortical bone. However, fatigue behavior (static and cyclic) and the presence of corrosion 
phenomena should also be considered. 
3- To obtain a homogeneous BG coating three layers were required (more layers compromises the 
integrity and adhesion of the coating). Nevertheless, it is important to control the rates, 
temperature and atmosphere of the thermal treatment in terms of BG crystallization and micro-
mechanical properties of the coating (presence of micro-porosity, as well as quality of union 
between the BG particles and the coating/substrate interface). 
4- The results suggests better osseointegration employing three BG coating layers on the substrates, 
due to greater formation of HA in contact with SBF. Nevertheless, the compromise between the 
thermal expansion coefficient (coating adherence to the substrate) and the bioactivity must be 
considered to choose the bioactive glass. 
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Table 1. Density and microstructural parameters of titanium substrates. 
Substrate 
Archimedes’ Method Image Analysis 
 
[g/cm
3
] 
Porosity (%) Total 
Porosity 
(%) 
Deq (m) Ff 
Total Interconnected 
Fully Dense 4.5 2.4 ± 0.3 0.4 ± 0.2 1.2 ± 0.2 5.5 ± 0.2 ~1 
Porous 2.4 ± 0.1 47.0 ± 1.0 44.3 ± 1.3 51.8 ± 1.3 161 ± 29 0.7 
 
 12 
 
 
Table 2. Micro-indentation (P-h) parameters of the substrates and coating. 
 A B C (B-A) (B-C)/B 
Bioactive glass 11.3 12.2 4.3 0.9 65.0 
Fully 
dense 
substrate 
C
o
at
in
g
 l
ay
er
s 
Without 17.5 18.3 11.7 0.9 36.3 
1 15.0 16.2 8.1 1.2 50.3 
3 19.1 20.4 11.8 1.2 42.2 
Porous 
substrate 
Without 21.7 23.1 10.3 1.4 55.5 
1 16.8 19.9 9.7 3.1 51.2 
3 27.4 30.0 18.6 2.5 38.0 
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Figure captions 
Figure 1. Experimental procedure: Fabrication and characterization of BG coated titanium 
substrates. 
Figure 2. Particle size distribution of a) Titanium c.p., b) Ammonium bicarbonate, c) BG particles. 
Figure 3. Macroscopic appearance of the coated titanium substrates before and after thermal 
treatment, influence of the number of coating layers (sample diameter: 12 mm). 
Figure 4. Confocal Images. Fully dense and porous substrate images for no coating (a), b)), one BG 
coating layer after thermal treatment (c), d)) and three BG coating layer after thermal treatment (e), 
f)). 
Figure 5. Applied load vs penetration depth curves for several substrate-coating systems 
investigated. The number of BG coating layers influences the P-h graphics for a) Fully dense and b) 
Porous samples. 
Figure 6. Schematic view of the top and cross section of coated porous substrate and SEM images 
of the cross sectional view of coated fully dense and porous substrates. Inset: detailed view of the 
chipping of the coating in the fully dense substrate. 
Figure 7. XRD patterns (left) and SEM images (right) for 45S5 BG particles and coated samples: 
A. 45S5 BG particles before sintering, B. 45S5 BG sintered sample. C. Porous cp-Ti substrate with 
one coating layer of 45S5 BG after 21 days in SBF and D. Porous cp-Ti substrate with three coating 
layers of 45S5 BG after 21 days in SBF. 
Figure 8. a) XRD patterns and b) SEM micrographs of fully dense cp-Ti sample with three BG 
coating layers showing massive formation of HA after 21 days in SBF. 
 14 
 
Figure 9. ICP data of: a) porous cp-Ti with one coating layer of BG, b) porous cp-Ti with three 
coating layer of BG and c) full dense cp-Ti with three coating layer of BG after 21 days in SBF. 
EDX spectra of: d) porous cp-Ti with one coating layer of BG, e) porous cp-Ti with three coating 
layer of BG and f) full dense cp-Ti with three coating layer of BG after 21 days in SBF. 
 15 
 
 
 
Figure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 
 
 
 
 
 
 
Figure 2. 
 
 16 
 
 
Figure 3. 
 17 
 
 
Figure 4.  
 18 
 
 
Figure 5. 
 
 
Figure 6. 
 
 19 
 
 
 
Figure 7. 
 20 
 
 
Figure 8 
 
 
 
 
 
 
Figure 9 
 
View publication stats
